Peter Salzmann M.D.

Peter Salzmann M.D.

Chief Executive Officer and Director at Immunovant, Inc.

Are you Peter Salzmann M.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Peter Salzmann M.D.'s network.
  • FOLLOW changes in Peter Salzmann M.D.'s employment.
  • CONNECT with Peter Salzmann M.D. through your network of contacts.

Peter Salzmann M.D.'s Executive Work History


Current
Board Member,
Board Member
Immunovant, Inc. DEF 14A on 06/26/2023
Immunovant, Inc.
Chief Executive Officer and Director,
Chief Executive Officer and Director
Immunovant, Inc. S-1 on 01/17/2020
Immunovant, Inc.
Board Member,
Board Member
Corbus Pharmaceuticals Holdings, Inc. DEF 14A on 04/03/2023
Corbus Pharmaceuticals Holdings, Inc.
Past
To view Peter Salzmann M.D.'s complete executive work history,
Age
55
 

Peter Salzmann M.D.'s Biography


Peter Salzmann, M.D., M.B.A, is the Chief Executive Officer of Immunovant and a member of our board of directors. From November 2018 to June 2019, he served as a Global Brand Development Leader in Immunology at Eli Lilly and Company, where he was responsible for the design of a comprehensive indication strategy and oversaw Phase 2 and 3 clinical trial execution. From March 2013 to October 2018, Dr. Salzmann was Head of U.S. Immunology at Eli Lilly, and he also served as Managing Director of Lilly Alps from January 2011 to April 2013. From January 2008 to December 2010, Dr. Sal... Read more

Source: Immunovant, Inc. on 09/11/2023

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Peter Salzmann M.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Peter Salzmann M.D.'s network.
  • FOLLOW changes in Peter Salzmann M.D.'s employment.
  • CONNECT with Peter Salzmann M.D. through your network of contacts.
 

Access over 2,000,000 executive and board member profiles.

Example: Peter Salzmann M.D.

Peter Salzmann M.D.'s Connections (160)


Jim Haney
Former Vice President, Financial Planning and Analysis, Immunovant, Inc.
John Strumbos PhD
Former Chief Financial Officer, Scipher Medicine Corp
Rod Saponjic PhD
Vice President of Clinical Operations, Immunovant, Inc.
Paola Mina-Osorio M.D., Ph.D.
Vice President of Medical Affairs, Immunovant, Inc.
Chau Cheng Ph.D., M.B.A.
Vice President of Investor Relations, Immunovant, Inc.
Beverly Paperiello
Former SVP, Program Strategy & CMO Chief of Staff, Immunovant, Inc.
Eva Renee Barnett
Chief Financial Officer, Immunovant, Inc.
Yuval Cohen Ph.D.
Chief Executive Officer and Director, Corbus Pharmaceuticals Holdings, Inc.
Yong Ben M.D.
Venture Partner, Eight Roads
Daniel Herz-Roiphe
Former Chief Operating Officer and General Counsel, Roivant Sciences Ltd.